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a b s t r a c t
Mild skeletal muscle symptoms might be accompanied with severe cardiac disease, some-
times indicating a serious inherited disorder. Very often it is a cardiologist who refers a
patient with cardiomyopathy and/or cardiac arrhythmia and discrete muscle disease for
neurological consultation, which helps to establish a proper diagnosis. Here we present
three families in which a diagnosis of skeletal muscle laminopathy was made after careful
examination of the members, who presented with cardiac arrhythmia and/or heart failure
and a mild skeletal muscle disease, which together with positive family history allowed to
direct the molecular diagnostics and then provide appropriate treatment and counseling.
© 2017 Published by Elsevier Sp. z o.o. on behalf of Polish Neurological Society.
Available online at www.sciencedirect.com
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Discrete skeletal muscle symptoms, which are associated with
cardiac disease and which are present especially in younger
patients sometimes could indicate a serious systemic inher-
ited disorder. The term ‘‘discrete symptom’’ usually describes
a mild symptom, which could bother patients, but it is not
disabling or it does not exclude them from everyday life.
Discrete symptoms are often neglected both by patient and by* Corresponding author at: Neuromuscular Unit, Mossakowski Medical R
Warsaw, Poland.
E-mail address: agamadpil@gmail.com (A. Madej-Pilarczyk).
http://dx.doi.org/10.1016/j.pjnns.2017.09.006
0028-3843/© 2017 Published by Elsevier Sp. z o.o. on behalf of Polish Nhis/her physician. Patients easily adapt to the restrictions,
associated with subclinical disease of skeletal muscles. This is
also related to a doctor who observes the symptoms, like
abnormal gait pattern, local muscle atrophy, mild muscle
weakness causing problems when climbing stairs or getting up
from the squatting position. Some skeletal muscle symptoms
or abnormal results of diagnostic test almost always lead to
diagnostic steps, e.g. joint contractures or elevated creatinine
kinase, while others need longer observation before any
diagnostic action, e.g. slight muscle weakness or pain, whichesearch Center, Polish Academy of Sciences, Pawinskiego 5, 02-106
eurological Society.
Fig. 1 – Pedigree of the Family 1. Note autosomal dominant
trait of inheritance.
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or psychosomatic disease. When similar muscle symptoms
are also found in patient's relatives, it could further support
the hypothesis of inherited disease: it helps to establish
a diagnosis, to calculate a risk of recurrence of a disease
in patient's progeny and to choose adequate therapeutic
approach.
Since the majority of genetic skeletal muscle diseases might
be associated with defect of cardiomyocytes and subsequent
cardiomyopathy with heart failure and/or arrhythmia, they are
increasingly perceived as systemic disorders and they are
treated by both neurologists and by cardiologists/internists [1].
Inherited skeletal muscle diseases with proved cardiological
component include but are not limited to dystrophinopathies
[4,5], Emery-Dreifuss muscular dystrophy (EDMD1) [2,3], in
limb-girdle muscular dystrophies (LGMD): sarcoglycanopathies
associated with defect in a-, b- g- or d-subunits of the
dystrophin-associated sarcoglycan complex (LGMD2D, E, C, F,
respectively) [6,7], titinopathies (LGMD2J) and LGMD2I associat-
ed with mutations in fukutin-related protein (FKRP), both types
of myotonic dystrophy (DM1, DM2) [8], nemalinopathies [9],
desminopathies [10] and Danon disease [11].
Patients with diagnosed heart disease presenting symp-
toms which are suggestive for skeletal muscle disease should
be asked about similar symptoms in their family members,
and their relatives should also consulted. It is important to
establish possible familial nature of a disease and trait of
inheritance (dominant, recessive) and to select genes for
molecular testing. Isolate discrete muscle symptoms, which
are to be looked for in family members, include e.g. slight
elbow and ankle contractures, muscle atrophy in hands,
shoulder instability, muscle pain, lack of reﬂexes, elevated
creatinine kinase (CK).
We present below a diagnostic approach which resulted in
diagnosis of skeletal muscle laminopathy in members of 3
different families. Initially they presented with cardiac failure
and/or arrhythmia what prompted them to search for medical
attention. Further detailed examination revealed then a mild
skeletal muscle disease, which together with positive family
history allowed to initiate molecular diagnostics and to
provide appropriate treatment and counseling.
2. Family reports
2.1. Family 1
31-years old male (II:2) was referred to a neuromuscular
consultation because of slowly progressing weakness of the
lower limbs, hindering from climbing stairs and getting up
from a squatting and sitting position. Since the school years he
was perceived as less agile than peers and he had worse results
in running. At the age of 31 he was implanted pacemaker DDD
type because of atrioventricular block (AVB) II grade (2:1) with
episodes of bradycardia of 21/min. Conduction disorders were
seen on ECG done routinely during obligatory periodic testing
at work. The patient did not report syncope; however he
noticed decreased tolerance of physical effort and periodic
edemas of the legs. On echocardiography borderline enlarge-
ment of the left atrium was found (4.2 cm) with generalhypokinesia of the left ventricle, while ejection fraction (EF)
was within the normal range (60%). NTproBNP was at the level
of 66.9 pg/mL (N < 400 pg/ml). On neurological examination
there were observed waddling gait, lumbar hyperlordosis,
slight elbow and ankle contractures, cervical spine rigidity,
slim shoulder girdle with preserved strength of arms and lack
of tendon reﬂexes in mm. biceps and mm. triceps. Diagnostic
tests showed moderately increased level of creatine kinase
(CK) – 404 U/l, then 310 U/l (N < 170 U/l). Electromyography
(EMG) revealed myopatic pattern in the m. biceps brachii. The
family history (Fig. 1) revealed that slight elbow contractures
and cervical spine rigidity were observed in 29-years old twin
sisters of the proband (II:3, II:5), and waddling gait in 52-years
old mother (I:1). Neurological examination was done in the
proband's mother (I:1), father (I:2), sister (II:3) and 18-years old
brother (II:7). The proband's mother (I:1) has been less agile
than peers since childhood. At the age of 35 there were noticed
problems with climbing stairs and standing from squatting
position. She did not seek medical attention. On neurological
examination waddling gait, lumbar hyperlordosis, slight
cervical spine rigidity and lack of Achilles tendon reﬂexes
were observed. No skeletal muscle wasting or contractures
were seen. Periodically she has palpitations. In previous ECG
atrioventricular block II Wenckebach type was found, but no
diagnostics was initiated then. At the age of 52 the patient was
qualiﬁed to a gynecological procedure. During routine evalua-
tion before surgery a conduction defect was found. On 24-
hours Holter monitoring AVB II Wenckebach type was
conﬁrmed again; it was leading to night bradycardia (HR 35/
min). In addition 3 pauses (the longest of 2.5 s) was seen. No
complex ventricular arrhythmia was observed. On echocardi-
ography borderline enlargement of the left atrium was found
(4.3 cm), slightly impaired diastolic function and decreased EF
(45%). NTproBNP was 40.3 pg/mL. At that time the patient I:1
had been implanted with a pacemaker DDD type. The
proband's father (I:2) was healthy. The proband's sister (II:3)
was weaker and less clever than peers. She had scoliosis. She
was not able to walk on heels. Since childhood cervical spine
rigidity and trace elbow contractures were noted. No muscle
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after greater physical efforts. 24-hour ECG monitoring revealed
night bradycardia of 35/min, with PQ 200 ms – borderline for
AVB I. Echocardiography was normal, with good systolic (EF
64%) and diastolic function of the left ventricle. Her ﬁrst
pregnancy was ended with spontaneous miscarriage in the 6th
week. She has two children: 6-years old son (III:2), clinically
healthy and 3-years old (III:3) son with trisomy 21. Family
history revealed that the second twin woman (II:5) is less agile
than her sister (II:3). Since childhood cervical spine rigidity,
lumbar hyperlordosis, elbow contractures and weakness of
proximal muscles of the legs were seen. Periodically she
reports pain and stinging sensation in the chest or cardiac
disease. 24-hour ECG monitoring revealed AVB I. Echocardiog-
raphy was normal, with good systolic function (EF 60%). She
has two daughters, the older one (III:4) is overweighed and less
agile than peers, the younger one (III:5) at presentation has not
presented any symptoms of skeletal muscle disease. The
proband's brother (II:7) is slim, at school he was less physically
ﬁt than peers. He easily gets tired. He is not able to walk on
heels. He has thoracic scoliosis, cervical spine rigidity and
slight elbow contractures. No muscle weakness was seen.
Periodically palpitations and postural hypotonia occur.
No conduction defect has been found until now, but
echocardiography revealed slightly decreased EF (50%). Sum-
mary of the neurological and cardiological evaluation is shown
in Tables 1 and 2.
Since the disease affected both men and women from two
consecutive generations (Fig. 1), we suspected muscular
dystrophy with cardiac involvement with autosomal domi-
nant trait of inheritance. There are presumptions indicating
EDMD2, associated with laminopathy: neurological presenta-
tion with dominating spine rigidity and joint contractures,
discrete and variable weakness of different muscle groups and
type of cardiac dysfunction in the proband, who had
atrioventricular block type II requiring pacemaker implanta-
tion. Once written informed consents had been acquired, we
performed genetic analysis in the proband, his parents,
siblings and siblings' children. Genomic DNA was extracted
from peripheral blood lymphocytes. All 12 exons of LMNA and
exon–intron boundaries were ampliﬁed by PCR, sequenced
using the Big Dye Terminator Sequencing Ready Reaction kitTable 1 – Neurological characteristics of the patients from Fam
Muscle weakness/
wasting
Reﬂexes 
mm.
quadriceps
mm.
biceps
mm.
biceps
Radial
bone
Knee 
Family 1
I:1 Yes/no No/no +  + 
II:2 Yes/no No/yes + + + 
II:3 No/no No/no  + + 
II:5 Yes/no No/yes 
II:7 No/yes No/yes +   
Family 2
III:6 Yes/no Yes/no    
Family 3
Proband Yes/yes Yes/yes + +  (Applied Biosystems), and analyzed on an ABI PRISM 373
ﬂuorescent DNA sequencer (Applied Biosystems). Primer
sequences and PCR protocols are available upon request.
Molecular testing revealed a heterozygous missense mutation
c.1355T>C, p.Val452Ala in exon 7 of LMNA gene, encoding
lamin A/C in several members of this family (Fig. 1): in the
proband, his mother, 4 siblings from the generation II and in 4
of 5 children from the generation III. The mutation was not
found in 110 control chromosomes. The family was included to
regular cardiological supervision. Genetic counseling was
provided.
2.2. Family 2
57-years old female was referred to neuromuscular consulta-
tion by a cardiologist. At the age of 47 the patient had been
implanted pacemaker because of atrioventricular block III
grade; at the age of 57 it was replaced by ICD (implantable
cardioverter-deﬁbrillator) due to deterioration of her cardiac
function (EF 15%). She underwent diagnostics because of
clinical signs of mild myopathy, but without deﬁnite molecular
diagnosis. On physical examination there was found de-
creased strength of quadriceps muscles, which resulted in
problems with climbing stairs and standing from squatting
position. Also, she could not stand on her heels. No muscle
wasting, no elbow contractures were seen. EMG revealed
myopatic pattern in m.biceps brachii. She also complained of
the spine stiffness, however MRI revealed osteoarthritis, so
this symptom could not be surely the attribute of any
underlying muscle disease. Clinical presentation in this
patient might be consistent with quadriceps myopathy or
mild limb-girdle muscular dystrophy (LGMD). Survey of the
family history revealed sudden cardiac deaths in young and
middle-aged members of this three generations family (Fig. 2).
Heart failure with conduction defect and mild skeletal muscle
disease directed the molecular diagnostics to laminopathies.
Molecular testing revealed the recurrent heterozygous mis-
sense mutation c.1130G>T, p.Arg377Leu in exon 6 of LMNA
gene. The only family members available for physical
examination and genetic testing were two adult sons of the
proband, but fortunately both they are free of the LMNA
mutation detected in their mother.ilies 1, 2 and 3.
Contractures Cervical
spine rigidity
Lumbar
hyperlordosis
Ankle Elbow Ankle
 No Trace Yes Yes
+ Yes Trace Yes Yes
+ Yes Trace Yes Yes
Yes Trace Yes Yes
+ Yes Trace Yes Yes
 No No Yes No
L/P +/ Trace Yes Yes Yes
Table 2 – Cardiological characteristics of the patients from Families 1, 2 and 3.
LA (cm) LVDD (cm) LVDS (cm) LVEF (%) Contractility Arrhythmia Cardiac device
Family 1
I:1 4.2 4.2 2 60 Normal Sporadic SVB, VB
AVBII Wenckebach,
bradycardia 21/min
Pacemaker DDD
(52 y)
II:2
Proband
4.3 5.1 3.3 45 General hypokinesia of
the left ventricle
AVBII 2:1, VB Pacemaker DDD
(31 y)
II:3 3.2 4.5 2.7 64 Normal Night bradycardia 35/min,
PQ 200ms
No
II:5 3.6 4.4 2.8 60 Normal AVBI No
II:7 2.9 4.0 2.5 50 Normal no No
Family 2
III:6
Proband
3.5 5.1 nd 15% Impaired AVBIII Pacemaker
(47 y)
ICD
(57 y)
Family 3
Proband 4.5 5.8 4.6 45% then
15%
Hypokinesia of IVS and
anterior wall of LV
AVBI/II Mobitz
2:1/Wenckebach,
bradycardia 26/min, AF,
AVBIII, sVT
Pacemaker VVI
(44 y)
ICD
(46 y)
CRT-D
(48 y)
Normal ranges: LA (left atrium): 1.9–4.0 cm; LVDD (left ventricle end-diastolic diameter): 3.5–5.6 cm; LVDS (left ventricle end-systolic diameter):
2.2–3.8 cm; LVEF (left ventricle ejection fraction): ≥55%.
SVB – supraventricular beats; VB – ventricular beats; AVB – atrioventricular block; AF – atrial ﬁbrillation; sVT – sustained ventricular
tachycardia; IVS – interventricular septum.
Fig. 2 – Pedigree of the Family 2. Note family members who died suddenly at young age.
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46-years old male with implanted with CRT-D (Cardiac
Resynchronization Therapy Implantable Cardioverter Deﬁbril-
lator) because of recurrent ventricular tachycardia (VT) with
high-energy intracardiac shocks and a very low EF (15%). Other
echocardiographic parameters were: LA – 4.5 cm; LVDD –
5.8 cm; LVDS – 4.6 cm. Two years earlier he had been
implanted with cardioverter deﬁbrillator (ICD-VR) because of
sustained VT; 4 years earlier he had been implanted with
pacemaker VVI due to atrial ﬁbrillation with AVB III; at thattime contractility of the left ventricle has been already
impaired, with EF of 45–50%. Asymptomatic AVB I/II Mobitz
2:1/Wenckebach, had been observed since the age of 25. The
patient was referred to neuromuscular consultation by a
cardiologist, however since childhood non-progressing mild
Achilles tendon and elbow contractures, slight spine rigidity
together with wasting and weakness of the proximal muscles
have been found. CK was 283 U/L. On electromyography
myogenic pattern was seen in m. deltoideus, m. vastus
lateralis and m. tibialis anterior. The clinical presentation
was the most likely consistent with EDMD2, however a clinical
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ing characteristic skeletal and cardiac muscle symptoms.
Family history was negative, so it did not provide any
suggestion on a potential trait of inheritance, but life-
threatening arrhythmia indicated with greater probability of
laminopathy than emerinopathy. In fact, molecular testing
revealed the recurrent heterozygous missense mutation
c.1357C>T (p.Arg453Trp) in exon 7 of LMNA gene.
3. Discussion
Laminopathies are rarely inherited diseases associated with
structural/functional defect of genes that encode the nuclear
envelope proteins. One of the best known one is lamin A/C, the
main component of nuclear lamina, which is encoded by
LMNA gene, located on chromosome 1 and translated on two
proteins, being splice variants – lamin A and lamin C.
Mutations in LMNA gene cause a wide spectrum of diseases
that affect tissues of mesenchymal origin [12]. Muscle
laminopathies create so-called organ-speciﬁc subgroups,
which include several phenotypes of various onset and
severity, from the most severe LMNA-related congenital
muscular dystrophy (L-CMD) [13] in children, EDMD [2,3],
LGMD1B [14], and isolated dilated cardiomyopathy with
conduction defects (CMD1A) [15]. This report presents patients
with discrete skeletal muscle disease associated with LMNA-
dependent phenotypes consistent with EDMD2, LGMD1B and
quadriceps myopathy, respectively.
EDMD is clinically characterized by humero-peroneal
muscle atrophy and weakness, multijoint contractures with
spine rigidity and cardiac insufﬁciency with conduction
defects in later decades of life [16,17]. Great intrafamilial
and interfamilial variability of clinical course of EDMD is seen
[18]. There are two main types of EDMD: EDMD1 associated
with mutations in EMD gene, encoding emerin, with X-linked
recessive inheritance [2] and EDMD2 associated with muta-
tions in LMNA gene, encoding lamin A/C, with autosomal
dominant inheritance [3].
When analyzing disease symptomatology in the Family 1,
we could note that in proband and his siblings the clinical
picture is consistent with EDMD2, while in their mother – with
quadriceps myopathy, although clinical course seems to be
mild. Weakness of mm. quadriceps was seen exclusively in
proband (II:2) and his mother (I:1). Contrary to the children (II:2,
II:3, II:5, II:7) their mother (I:1) did not have elbow contractures.
All affected patients had cervical spine rigidity, lumbar
hyperlordosis and trace Achilles tendon contractures. Se-
quence and severity of cardiological and skeletal muscle
symptoms might vary individually. Therefore observation
toward discrete muscle symptoms could be of great impor-
tance to ﬁnd etiology of severe heart disease in young patients
with idiopathic cardiomyopathy, paroxysmal arrhythmia
(supraventricular tachycardia, atrial ﬂutter/ﬁbrillation), atrio-
ventricular block, sick sinus syndrome, especially when
sudden cardiac deaths/heart disease/skeletal muscle disease
were identiﬁed in family history. Conduction defects, which
required cardiological procedure (pacemaker implantation)
has been diagnosed so far in two members of the Family 1:
proband (II:2) and his mother (I:1). Although slight proximalmuscle weakness in proband was present before asymptom-
atic arrhythmia, initially no neurological diagnostics was
initiated. Correlation of cardiac failure and/or arrhythmia and
discrete skeletal muscle symptoms helped to direct of
diagnostics toward genetic disease. Conﬁrmation of laminop-
tahy in proband initiated molecular testing in other members
of his family, who presented similar slight muscle and joint
symptoms: elbow contractures, cervical spine rigidity and
hyperlordosis.
The proband's, mother has been implanted with pacemak-
er after conﬁrmation of the atrio-ventricular block II and
decreased ejection fraction (45%). It has been suggested that
implantation of a pacemaker could not be sufﬁcient to prevent
sudden cardiac death in some patients with laminopathy,
namely with non-sustained ventricular tachycardia, left
ventricle EF < 45%, male sex and non-missense mutation in
LMNA gene [19]. As one of the four risk factors listed above is
present in the patient I:1, i.e. borderline EF, she requires re-
evaluation toward qualiﬁcation to implantable cardioverter-
deﬁbrillator. In case of the female from Family 2 the main
reason to replace pacemaker with ICD was gradual deteriora-
tion of cardiac function, with decrease of EF to 15%. The patient
from Family 3 had three of four risk factors of SCD in
laminopathy, listed in the paper of van Rijsingen et al. [19] i.e.
VT, male sex and EF < 45%, ﬁnally he required implantation of
CRT-D. Although until now no cardiac arrhythmia requiring
electrotherapy has been found in the siblings of the proband
from Family 1 (i.e. II:3, II:5, II:7), they require annual follow-up,
which should include physical examination, ECG, Holter
monitoring and echocardiography, which is recommended
not only in all carriers of LMNA mutation, but in all patients
with muscular dystrophies, even asymptomatic and with
normal ECG [20,21].
In addition to cardiac failure, requiring implantation of
cardioverter-deﬁbrillator in primary prevention of SCD, the
proband from the Family 2 presented also signs that might
correspond to quadriceps myopathy or mild LGMD, but
without previous deﬁnite diagnosis, despite some attempts.
Positive family history toward SCD in numerous young and
middle-aged members of consecutive generations in this
family, which indicated autosomal-dominant trait of inheri-
tance, allowed to direct the diagnostics to laminopathies. In
fact, the recurrent mutation in LMNA gene: c.1130G>T (p.
Arg377Leu) was detected; it had been previously described in
patients with EDMD2 [22], LGMD1B [23], DCM-CD [24], quadri-
ceps myopathy with DCM-CD [9] and EDMD2 with peripheral
neuropathy [25].
Phenotype of the patient from the Family 3 was consistent
with EDMD2, but non-progressing muscle weakness and mild
joint contractures with quite good physical ability prevented
him to seek neurological diagnosis at younger age. Severe
cardiological involvement which occurred in his ﬁfth decade of
life, in association with skeletal muscle symptoms, directed
diagnostic pathway to inherited disease and it was the
cardiologist who was the ﬁrst specialist referring this patient
to neuromuscular center. The disease-causing mutation in
exon 7 of LMNA gene, i.e. c.1357C>T (p.Arg453Trp), has been
reported in other EDMD2 patients, also of Polish origin [26,27].
Discrete muscular symptoms and signs observed in all
patients with laminopathy presented above were the main
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neurological and genetic consultations. It was a cardiac
disease which trigger diagnostics toward neuromuscular
disease, mainly due to high awareness of cardiologists, who
were the ﬁrst specialists asked for consultation. It should also
be stressed that laminopathies may manifest as isolated
cardiac disease (DCM-CD) and the later muscle symptoms
appear, the less severe and easier to overlooked they might be.
Patients are often well-adapted to them, so they do not seek
medical attention. Only serious cardiac disease or sudden
cardiac deaths in family raise the signiﬁcance of genetic
diagnosis and proper counseling. LMNA gene mutations are
characterized by almost full penetration as for heart disease in
adulthood and constitute a real threat to life if left undiag-
nosed and untreated. Establishing diagnosis of laminopathy
may be crucial since these patients may require implantation
of the ICD instead of the classic pacemaker due to signiﬁcantly
higher risk of sudden death spawned by ventricular tachyar-
rhythmia which is not preventable by pacemaker itself. The 57
years old female patient from the family 2 might be a good
example of this strategy.
Finally, discrete muscle symptoms should not be under-
estimated. Carefully collected history, physical examination,
diagnostic procedures would help in shaping so as not to
overlook the systemic disease. Patients and carriers with
subtle skeletal muscle symptoms/signs are to be routinely sent
to cardiologists for early recognition and treatment of
cardiomyopathy and/or life-threatening arrhythmias. Cur-
rently, screening for cardiac should be offered to all patients
suspected/diagnosed with muscular dystrophy or myopathy
[21]. Identiﬁcation of all patients in the family presenting
subclinical symptoms of muscle disease and determination of
proper diagnosis might help establishing therapeutic ap-
proach, as well as genetic and career counseling.
Conﬂict of interest
None declared.
Author's contributions
Study concept and design: AMP. Clinical assessment and data
collection: AMP, MM, KO, JC, RS. Molecular analysis: AMP, KO.
Data analysis and interpretation: AMP, MM, KO, JC, RS.
Manuscript preparation: AMP, MM, KO.
Acknowledgement and ﬁnancial support
This study was supported by a grant from the Polish National
Science Centre No. 2015/17/B/NZ5/01368.
Ethics
All procedures were conducted in accordance with the
standards of the bioethical committee and the Declaration
of Helsinki.r e f e r e n c e s
[1] Verhaert D, Richards K, Rafael-Fortney JA, Raman SV.
Cardiac involvement in patients with muscular
dystrophies: magnetic resonance imaging phenotype and
genotypic considerations. Circ Cardiovasc Imaging 2011;
4(1):67–76.
[2] Bione S, Maestrini E, Rivella S, Mancini M, Regis S, Romeo G,
et al. Identiﬁcation of a novel X-linked gene responsible for
Emery-Dreifuss muscular dystrophy. Nat Genet 1994;
8(4):323–7.
[3] Bonne G, Di Barletta MR, Varnous S, Becane HM,
Hammouda EH, Merlini L, et al. Mutations in the
gene encoding lamin A/C cause autosomal dominant
Emery-Dreifuss muscular dystrophy. Nat Genet 1999;
21(3):285–8.
[4] Finsterer J, Stöllberger C. The heart in human
dystrophinopathies. Cardiology 2003;99(1):1–19.
[5] Russell MW, Townsend D, Metzger JM. Cardiac involvement
in the dystrophinopathies. J Pediatr Rehabil Med 2008;1
(3):211–23.
[6] Semplicini C, Vissing J, Dahlqvist JR, Stojkovic T, Bello L,
Witting N, et al. Clinical and genetic spectrum in limb-
girdle muscular dystrophy type 2E. Neurology 2015;
84(Apr (17)):1772–81.
[7] Fayssoil A, Ogna A, Chaffaut C, Chevret S, Guimarães-Costa
R, Leturcq F, et al. Natural history of cardiac and
respiratory involvement, prognosis and predictive factors
for long-term survival in adult patients with limb girdle
muscular dystrophies type 2C and 2D. PLOS ONE 2016;
11(4):e0153095.
[8] Bienias P, Łusakowska A, Ciurzyński M, Rymarczyk Z, Irzyk
K, Kurnicka K, et al. Supraventricular and ventricular
arrhythmias are related to the type of myotonic dystrophy
but not to disease duration or neurological status. Pacing
Clin Electrophysiol 2016;39(9):959–68.
[9] Finsterer J, Stöllberger C. Review of cardiac disease in
nemaline myopathy. Pediatr Neurol 2015;53(6):473–7.
[10] Goldfarb LG, Olivé M, Vicart P, Goebel HH. Intermediate
ﬁlament diseases: desminopathy. Adv Exp Med Biol
2008;642:131–64.
[11] Boucek D, Jirikowic J, Taylor M. Natural history of Danon
disease. Genet Med 2011;13(6):563–8.
[12] Worman HJ, Bonne G. ‘‘Laminopathies’’: a wide spectrum of
human diseases. Exp Cell Res 2007;313(10):2121–33.
[13] Quijano-Roy S, Mbieleu B, Bönnemann CG, Jeannet PY,
Colomer J, Clarke NF, et al. De novo LMNA mutations cause
a new form of congenital muscular dystrophy. Ann Neurol
2008;64(2):177–86.
[14] Muchir A, Bonne G, van der Kooi AJ, van Meegen M,
Baas F, Bolhuis PA, et al. Identiﬁcation of mutations
in the gene encoding lamins A/C in autosomal dominant
limb girdle muscular dystrophy with atrioventricular
conduction disturbances (LGMD1B). Hum Mol Genet
2000;9:1453–9.
[15] Fatkin D, MacRae C, Sasaki T, Wolff MR, Porcu M, Frenneaux
M, et al. Missense mutations in the rod domain of the lamin
A/C gene as causes of dilated cardiomyopathy and
conduction-system disease. N Engl J Med 1999;341:1715–24.
[16] Maggi L, Carboni N, Bernasconi P. Skeletal muscle
laminopathies: a review of clinical and molecular features.
Cells 2016;5(3). pii: E33.
[17] Bonne G, Quijano-Roy S. Emery-Dreifuss muscular
dystrophy, laminopathies, and other nuclear
envelopathies. Handb Clin Neurol 2013;113:1367–76.
[18] Rankin J, Auer-Grumbach M, Bagg W, Colclough K, Nguyen
TD, Fenton-May J, et al. Extreme phenotypic diversity and
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 2 ( 2 0 1 8 ) 1 7 4 – 1 8 0180nonpenetrance in families with the LMNA gene mutation
R644C. Am J Med Genet A 2008;146A(12):1530–42.
[19] van Rijsingen IA, Arbustini E, Elliott PM, Mogensen J,
Hermans-van Ast JF, van der Kooi AJ, et al. Risk factors for
malignant ventricular arrhythmias in lamin A/C mutation
carriers a European cohort study. J Am Coll Cardiol 2012;59
(5):493–500.
[20] Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N,
Borggrefe M, Camm J, et al. 2015 ESC Guidelines for the
management of patients with ventricular arrhythmias and
the prevention of sudden cardiac death: The Task Force for
the Management of Patients with Ventricular Arrhythmias
and the Prevention of Sudden Cardiac Death of the
European Society of Cardiology (ESC). Endorsed by:
Association for European Paediatric and Congenital
Cardiology (AEPC). Eur Heart J 2015;36(41):2793–867.
[21] Hermans MC, Pinto YM, Merkies IS, de Die-Smulders CE,
Crijns HJ, Faber CG. Hereditary muscular dystrophies and
the heart. Neuromuscul Disord 2010;20(8):479–92.
[22] van Tintelen JP, Hofstra RM, Katerberg H, Rossenbacker T,
Wiesfeld AC, du Marchie Sarvaas GJ, et al. High yield of
LMNA mutations in patients with dilated cardiomyopathy
and/or conduction disease referred to cardiogenetics
outpatient clinics. Am Heart J 2007;154:1130–9.[23] Perrot A, Sigusch HH, Nägele H, Genschel J, Lehmkuhl H,
Hetzer R, et al. Genetic and phenotypic analysis
of dilated cardiomyopathy with conduction system disease:
demand for strategies in the management of
presymptomatic lamin A/C mutant carriers. Eur J Heart Fail
2006;8:484–93.
[24] Charniot JC, Desnos M, Zerhouni K, Bonnefont-Rousselot D,
Albertini JP, Salama JZ, et al. Severe dilated cardiomyopathy
and quadriceps myopathy due to lamin A/C gene mutation:
a phenotypic study. Eur J Heart Fail 2006;8:249–56.
[25] Madej-Pilarczyk A, Kotruchow K, Kabzińska D, Cegielska J,
Kochański A, Hausmanowa-Petrusewicz I. Emery-Dreifuss
muscular dystrophy type 2 associated (?) with mild
peripheral polyneuropathy. Folia Neuropathol 2015;
53(3):270–4.
[26] Niebroj-Dobosz I, Madej-Pilarczyk A, Marchel M,
Sokołowska B, Hausmanowa-Petrusewicz I. Circulating
tenascin-C levels in patients with dilated cardiomyopathy
in the course of Emery-Dreifuss muscular dystrophy. Clin
Chim Acta 2011;412(17–18):1533–8.
[27] Hausmanowa-Petrusewicz I, Madej-Pilarczyk A, Marchel M,
Opolski G. Emery-Dreifuss dystrophy: a 4-year follow-up on
a laminopathy of special interest. Neurol Neurochir Pol
2009;43(5):415–20.
